Chronic mitral valve disease due to myxomatous degeneration (MMVD) is the most common
cardiovascular disease in dogs and has been known to cause congestive heart failure for …

The evaluation of cardiac disease in small animals can be challenging. The patient history is
often nonspecific; the presence or intensity of a heart murmur on physical examination is not …

Background Broadly applicable reference intervals (RIs) for measurements of left atrial (LA)
and left ventricular (LV) size and function generated prospectively using statistically …

Background Preclinical myxomatous mitral valve degeneration (MMVD) includes a
heterogeneous group of dogs. Therefore, identifying risk factors for progression of the …

OBJECTIVE: To identify risk factors for first-onset congestive heart failure (CHF) in dogs with
degenerative mitral valve disease (DMVD). ANIMALS: Eighty-two dogs with and without …

Background Changes in clinical variables associated with the administration of pimobendan
to dogs with preclinical myxomatous mitral valve disease (MMVD) and cardiomegaly have …

Background There is no commonly shared severity score for myxomatous mitral valve
disease (MMVD) based on routinely acquired echocardiographic variables …

Objectives To evaluate vena contracta and other echocardiographic measures of
myxomatous mitral valve disease (MMVD) severity in a multivariable analysis of survival in …

Background Identification of factors associated with decreased survival in dogs with
degenerative mitral valve disease (DMVD) will allow more accurate prognosis. N‐terminal …

Introduction Left ventricular (LV) and left atrial (LA) enlargement affect management and
outcome of dogs with cardiac disease. Short-axis, two-dimensional echocardiographic …